Literature DB >> 9374866

Mapping the binding site for matrix metalloproteinase on the N-terminal domain of the tissue inhibitor of metalloproteinases-2 by NMR chemical shift perturbation.

R A Williamson1, M D Carr, T A Frenkiel, J Feeney, R B Freedman.   

Abstract

Changes in the NMR chemical shift of backbone amide nuclei (1H and 15N) have been used to map the matrix metalloproteinase (MMP) binding site on the N-terminal domain of the tissue inhibitor of metalloproteinase-2 (N-TIMP-2). Amide chemical shift changes were measured on formation of a stable complex with the catalytic domain of stromelysin-1 (N-MMP-3). Residues with significantly shifted amide signals mapped specifically to a broad site covering one face of the molecule. This site (the MMP binding site) consists primarily of residues 1-11, 27-41, 68-73, 87-90, and 97-104. The site overlaps with the OB-fold binding site seen in other proteins that share the same five-stranded beta-barrel topology. Sequence conservation data and recent site-directed mutagenesis studies are discussed in relation to the MMP binding site identified in this work.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9374866     DOI: 10.1021/bi9712091

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  44 in total

Review 1.  How matrix metalloproteinases regulate cell behavior.

Authors:  M D Sternlicht; Z Werb
Journal:  Annu Rev Cell Dev Biol       Date:  2001       Impact factor: 13.827

2.  Determining binding sites in protein-nucleic acid complexes by cross-saturation.

Authors:  A N Lane; G Kelly; A Ramos; T A Frenkiel
Journal:  J Biomol NMR       Date:  2001-10       Impact factor: 2.835

Review 3.  Structural basis of matrix metalloproteinases and tissue inhibitors of metalloproteinases.

Authors:  Klaus Maskos; Wolfram Bode
Journal:  Mol Biotechnol       Date:  2003-11       Impact factor: 2.695

4.  Automated evaluation of chemical shift perturbation spectra: New approaches to quantitative analysis of receptor-ligand interaction NMR spectra.

Authors:  Chen Peng; Stephen W Unger; Fabian V Filipp; Michael Sattler; Sándor Szalma
Journal:  J Biomol NMR       Date:  2004-08       Impact factor: 2.835

5.  Structure, dynamics and interactions of p47, a major adaptor of the AAA ATPase, p97.

Authors:  Xuemei Yuan; Peter Simpson; Ciaran McKeown; Hisao Kondo; Keiji Uchiyama; Russell Wallis; Ingrid Dreveny; Catherine Keetch; Xiaodong Zhang; Carol Robinson; Paul Freemont; Stephen Matthews
Journal:  EMBO J       Date:  2004-03-18       Impact factor: 11.598

6.  Ribosome clearance by FusB-type proteins mediates resistance to the antibiotic fusidic acid.

Authors:  Georgina Cox; Gary S Thompson; Huw T Jenkins; Frank Peske; Andreas Savelsbergh; Marina V Rodnina; Wolfgang Wintermeyer; Steve W Homans; Thomas A Edwards; Alexander J O'Neill
Journal:  Proc Natl Acad Sci U S A       Date:  2012-01-20       Impact factor: 11.205

7.  A general algorithm for peak-tracking in multi-dimensional NMR experiments.

Authors:  P Ravel; G Kister; T E Malliavin; M A Delsuc
Journal:  J Biomol NMR       Date:  2007-02-10       Impact factor: 2.835

8.  Conformational heterogeneity in antibody-protein antigen recognition: implications for high affinity protein complex formation.

Authors:  Philip W Addis; Catherine J Hall; Shaun Bruton; Vaclav Veverka; Ian C Wilkinson; Frederick W Muskett; Philip S Renshaw; Christine E Prosser; Bruce Carrington; Alastair D G Lawson; Robert Griffin; Richard J Taylor; Lorna C Waters; Alistair J Henry; Mark D Carr
Journal:  J Biol Chem       Date:  2014-01-16       Impact factor: 5.157

9.  Crystal structure of the complex formed by the membrane type 1-matrix metalloproteinase with the tissue inhibitor of metalloproteinases-2, the soluble progelatinase A receptor.

Authors:  C Fernandez-Catalan; W Bode; R Huber; D Turk; J J Calvete; A Lichte; H Tschesche; K Maskos
Journal:  EMBO J       Date:  1998-09-01       Impact factor: 11.598

10.  Discovery and binding studies on a series of novel Pin1 ligands.

Authors:  Bainan Wu; Michele F Rega; Jun Wei; Hongbin Yuan; Russell Dahl; Ziming Zhang; Maurizio Pellecchia
Journal:  Chem Biol Drug Des       Date:  2009-04       Impact factor: 2.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.